(Total Views: 105)
Posted On: 01/30/2017 8:00:20 PM
Post# of 99130
At least $RVXCF is one of the 37.....
I picked TBIO two weeks in a row, thinking it had another pop in it....finally moved on, now watch TBIO explode this week.
Resverlogix has a chance to be absolutely massive imo with their lead compound in a phase III clinical trial for Diabetes Mellitus. Diabetes is nothing short of a world wide epidemic, and most with full blown insulin dependent diabetics, no matter how well they maintain their blood sugar levels, they're likely to suffer from a heart attack, stroke or even death.
Epigenetics is going to be a huge area in my opinion....turning genes off and on through things called writers and erasers has the potential to completely transform the pharma industry....
I picked TBIO two weeks in a row, thinking it had another pop in it....finally moved on, now watch TBIO explode this week.
Resverlogix has a chance to be absolutely massive imo with their lead compound in a phase III clinical trial for Diabetes Mellitus. Diabetes is nothing short of a world wide epidemic, and most with full blown insulin dependent diabetics, no matter how well they maintain their blood sugar levels, they're likely to suffer from a heart attack, stroke or even death.
Epigenetics is going to be a huge area in my opinion....turning genes off and on through things called writers and erasers has the potential to completely transform the pharma industry....
(1)
(0)
Check out my blog if you like: Avoid The Bag
